Monthly Archives: October 2008
People shouldn't let last year's flu vaccine debacle prevent them from getting a flu shot this year -- and that includes diabetics.
Researchers have identified a particular subset of cells that are linked to obesity-associated insulin resistance, and that offer a promising new target for the treatment of diabetes.
In a large U.S. population-based study, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.
Mayo Clinic researchers have found what may provide a solution to one of the more troubling complications of diabetes -- delayed gastric emptying or gastroparesis.
A 55-year-old grandmother is producing insulin on her own after her islet cells were removed from her pancreas and implanted into her forearm a few weeks ago at The Methodist Hospital in Houston.
Researchers have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. The breakthrough may one day lead to new treatments or even a cure for the millions of people affected by the disease, researchers say.
Pre-mixed insulin analogues, a modified form of conventional pre-mixed human insulin, are more effective than long-acting analogues for controlling high blood sugar levels after meals in patients with type 2 diabetes.
Hypoglycemia is difficult to treat, particularly in children younger than five years of age, because of difficulties in administering the correct glucose dose as well as patient compliance. Researchers presented data that demonstrated how a new approach that could change the way this disorder is managed in millions of pediatric diabetes patients worldwide.
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members.